[go: up one dir, main page]

DK1645558T3 - Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer - Google Patents

Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Info

Publication number
DK1645558T3
DK1645558T3 DK05023471T DK05023471T DK1645558T3 DK 1645558 T3 DK1645558 T3 DK 1645558T3 DK 05023471 T DK05023471 T DK 05023471T DK 05023471 T DK05023471 T DK 05023471T DK 1645558 T3 DK1645558 T3 DK 1645558T3
Authority
DK
Denmark
Prior art keywords
serotonin
piperazinylpyrazines
receptor modulators
ht2c receptor
relates
Prior art date
Application number
DK05023471T
Other languages
English (en)
Inventor
Magnus Cernerud
Helena Lundstroem
Claes Loefstroem
Margit Pelcman
Tom Fleck
Alexander Paptchikhine
Emma Andersson
Alf Nygren
Original Assignee
Biovitrum Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx
Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx
Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx
Application filed by Biovitrum Ab Publ filed Critical Biovitrum Ab Publ
Application granted granted Critical
Publication of DK1645558T3 publication Critical patent/DK1645558T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Luminescent Compositions (AREA)
DK05023471T 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer DK1645558T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0201881A SE0201881D0 (sv) 2002-06-19 2002-06-19 Novel compounds, their use, and preparation
US39065602P 2002-06-21 2002-06-21
SE0202041A SE0202041D0 (sv) 2002-06-28 2002-06-28 Novel process
US40611902P 2002-08-26 2002-08-26
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
US41670102P 2002-10-07 2002-10-07
PCT/SE2003/001043 WO2004000829A1 (en) 2002-06-19 2003-06-18 Novel process

Publications (1)

Publication Number Publication Date
DK1645558T3 true DK1645558T3 (da) 2008-10-06

Family

ID=30004077

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03736405T DK1529043T3 (da) 2002-06-19 2003-06-18 Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater
DK05023471T DK1645558T3 (da) 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03736405T DK1529043T3 (da) 2002-06-19 2003-06-18 Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater

Country Status (16)

Country Link
EP (2) EP1645558B1 (da)
JP (4) JP4592417B2 (da)
CN (1) CN100334082C (da)
AT (2) ATE398119T1 (da)
AU (1) AU2003237746B8 (da)
CA (1) CA2485532C (da)
CY (1) CY1106225T1 (da)
DE (2) DE60307286T2 (da)
DK (2) DK1529043T3 (da)
ES (2) ES2307102T3 (da)
HK (1) HK1080079B (da)
NO (1) NO20050279D0 (da)
NZ (1) NZ536663A (da)
PT (2) PT1529043E (da)
SI (2) SI1529043T1 (da)
WO (1) WO2004000829A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
RU2464269C2 (ru) 2007-10-16 2012-10-20 Дайити Санкио Компани, Лимитед Пиримидилиндолиновое соединение
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
DK2442870T3 (da) 2009-06-15 2014-06-30 Takeda Pharmaceutical Pyrazinooxazepin-derivater.
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
GB201304811D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Novel treatment for hypertension
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06306075A (ja) * 1993-04-23 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd エトキシベンズアミド誘導体
CN1242995C (zh) * 1999-05-21 2006-02-22 比奥维特罗姆股份公司 化合物,它们的用途和制备方法
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
EA005975B1 (ru) * 2000-11-20 2005-08-25 Биовитрум Аб Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора

Also Published As

Publication number Publication date
NO20050279D0 (no) 2005-01-18
JP2013227336A (ja) 2013-11-07
ATE334980T1 (de) 2006-08-15
PT1529043E (pt) 2006-12-29
JP2005537316A (ja) 2005-12-08
EP1529043B1 (en) 2006-08-02
AU2003237746B8 (en) 2010-01-28
JP5378241B2 (ja) 2013-12-25
HK1080079B (zh) 2008-03-14
SI1529043T1 (sl) 2006-12-31
DK1529043T3 (da) 2006-12-04
EP1645558B1 (en) 2008-06-11
CY1106225T1 (el) 2011-06-08
JP2010120949A (ja) 2010-06-03
DE60307286T2 (de) 2007-10-25
NZ536663A (en) 2007-05-31
WO2004000829A1 (en) 2003-12-31
ATE398119T1 (de) 2008-07-15
PT1645558E (pt) 2008-07-30
EP1529043A1 (en) 2005-05-11
ES2270051T3 (es) 2007-04-01
DE60321606D1 (de) 2008-07-24
EP1645558A1 (en) 2006-04-12
SI1645558T1 (sl) 2008-10-31
CN100334082C (zh) 2007-08-29
HK1080079A1 (zh) 2006-04-21
AU2003237746B2 (en) 2009-12-17
AU2003237746A1 (en) 2004-01-06
CA2485532C (en) 2012-03-06
JP4592417B2 (ja) 2010-12-01
JP2013116906A (ja) 2013-06-13
DE60307286D1 (de) 2006-09-14
CN1662523A (zh) 2005-08-31
CA2485532A1 (en) 2003-12-31
ES2307102T3 (es) 2008-11-16

Similar Documents

Publication Publication Date Title
BR0311494A (pt) Novos indóis substituìdos
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
SE0202241D0 (sv) Novel Compounds
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
BRPI0410711A (pt) novos compostos
DK1379246T3 (da) Nocieptin-analoger
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
EA200970326A1 (ru) Алкильные производные в качестве метаботропных рецепторов глутамата
EA200601798A1 (ru) Замещенные соединения морфолина для лечения расстройств центральной нервной системы
EA201070143A1 (ru) Новые гетероароматические производные и их использование в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
ECSP034811A (es) Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6
DK1461318T3 (da) Tetrahydroquinolinanaloge som muscariniske agonister
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
EA200601895A1 (ru) 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
MX2007002393A (es) Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
SE0502254L (sv) Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
DK1645558T3 (da) Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
ATE499099T1 (de) Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
ATE418973T1 (de) Spirocyclopropyl-amide und -säuren und ihre therapeutischen anwendungen